Endothelial cell regulation of cardiac metabolism following diabetes

Cardiovasc Hematol Disord Drug Targets. 2014;14(2):121-5. doi: 10.2174/1871529x14666140505123221.

Abstract

The earliest change that occurs in the diabetic heart is reduced glucose consumption, with a switch to utilization of fatty acids (FA) predominantly as an energy resource. Although this adaptation might be beneficial in the short-term, over a protracted duration, it is potentially catastrophic given the malicious effects produced by high FA in cardiomyocytes. In this review, we describe how the endothelial cell (EC), a "first-responder" to hyperglycemia, communicates with the underlying cardiomyocyte. As this cross-talk is expected to facilitate increased FA delivery to, and utilization by, the cardiomyocyte, understanding this conversationshould assist in devising new therapeutic strategies to prevent or delay diabetic heart disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Diabetes Mellitus / metabolism*
  • Diabetes Mellitus / pathology
  • Diabetic Cardiomyopathies / etiology
  • Diabetic Cardiomyopathies / metabolism*
  • Diabetic Cardiomyopathies / pathology
  • Endothelial Cells / metabolism
  • Endothelial Cells / pathology*
  • Fatty Acids / metabolism
  • Glucuronidase / metabolism
  • Humans
  • Hyperglycemia / complications
  • Hyperglycemia / metabolism
  • Hyperglycemia / pathology
  • Lipoprotein Lipase / metabolism
  • Myocardium / metabolism
  • Myocardium / pathology*
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / pathology
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Fatty Acids
  • Vascular Endothelial Growth Factor A
  • Lipoprotein Lipase
  • heparanase
  • Glucuronidase